4.4 Article

Teriflunomide: Pediatric First Approval

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis

Gabrielle Macaron et al.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)

Review Pharmacology & Pharmacy

Mechanism of action of three newly registered drugs for multiple sclerosis treatment

Kaja Kasarello et al.

PHARMACOLOGICAL REPORTS (2017)

Article Clinical Neurology

Extensive Acute Axonal Damage in Pediatric Multiple Sclerosis Lesions

Sabine Pfeifenbring et al.

ANNALS OF NEUROLOGY (2015)

Review Pharmacology & Pharmacy

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

Amit Bar-Or et al.

DRUGS (2014)

Article Clinical Neurology

Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years

L. A. Benson et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)

Article Medicine, General & Internal

Natural history of multiple sclerosis with childhood onset

Christel Renoux et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)